GeneQuantum Healthcare, a Chinese high-tech company focused on the research and development of innovative bio-therapeutics, announced on Wednesday that it has raised nearly RMB100 million (US$14.76 million) in a pre-B round of financing led by private equity firm Huagai Capital.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 2 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.Register Basic Account
Subscribe for an annual subscription!
Enjoy comprehensive and exclusive data you can't find elsewhere!More Info
Already have an account or paid subscription?